Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/RELMADA-THERAPEUTICS-INC-73538250/news/Relmada-Therapeutics-Inc-schlie-t-Nachtrag-Nr-2-zur-Lizenzvereinbarung-ab-42632253/?utm_source=whatsapp&utm_medium=social&utm_campaign=share